Archive

The Competition Commission is investigating insulin manufacturers Novo Nordisk and Sanofi Aventis, raising concerns about accessibility to diabetes care.

The Trump administration’s abrupt termination of USAID grants has jeopardised SA’s fight against HIV/AIDS, threatening health services and thousands of jobs.

Despite its promise, access to Lenacapavir, a revolutionary HIV prevention injection which stops 100% of new HIV infections in women and girls, is restricted.

ObesityWeek 2024 attracted unprecedented attention from Wall Street, highlighting obesity treatment’s booming pharmaceutical industry.

Experts warn that a proposal to use Public Investment Corporation (PIC) funds for NHI is misguided as these funds belong to government employees/pensioners.

The GIBS October Health Workplace Well-being report reveals the state of employee mental health and the impact of workplace environments.

In 2023, the global wellness industry reached a remarkable $6.32 trillion valuation, surpassing the combined size of the sports and pharmaceutical industries. This figure, reported by the Global Wellness Institute (GWI), marks a 25% growth since 2019, driven by a surge in demand for health-focused products and services post-pandemic. The GWI defines wellness as “the […]

The Department of Health and National Treasury are exploring using the R2.3-trillion savings pool, managed by the PIC, to fund health infrastructure upgrades.

South Africa’s health budget 2024 under scrutiny after Minister’s statement, sparking concerns among activists and unions.

New Zealand customs has seized semaglutide-based drugs made in Bangladesh, underscoring a rise in global demand for cheaper alternatives to Ozempic.

In 2023, tuberculosis was the top infectious disease killer worldwide, with 1.25 million deaths. SA’s TB incidence is declining, but fatalities remain high.